Clinical trial Recruiting at 1 site Interventional Ages 38 and up

Perineural prolotherapy for chronic knee osteoarthritis pain

Official title: Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain: A Randomized Controlled Trial.

Run by National and Kapodistrian University of Athens · NCT07245121 · Data updated 2026-11-12

This trial will test whether adding 5% dextrose to perineural injections reduces pain in adults with chronic knee osteoarthritis.

Quick facts

Study typeInterventional
Ages38 Years and up
SexAll
Enrollment60 (estimated)
SponsorNational and Kapodistrian University of Athens
Academic / other
Locations1 site (Athens, Attica)
StatusRecruiting
StartedNovember 24, 2025
Main results expectedDecember 2026
Study endsFebruary 2027
Registry record updatedDecember 2, 2025
Trial IDNCT07245121 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults older than 38 with symptomatic knee osteoarthritis (Kellgren-Lawrence grade 2–3), persistent moderate–severe pain (NRS >5) for at least three months, and BMI up to 42 may be eligible.

Probably not a fit

Patients with very advanced osteoarthritis (KL grade 4), active knee infection, recent knee surgery, or lower pain levels are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized controlled trial compares perineural prolotherapy using 5% dextrose plus local anesthetic versus local anesthetic alone, delivered to four genicular nerve sites around the knee. Ultrasound guidance is used to place injections at the superomedial, superolateral, inferomedial, and recurrent peroneal genicular nerves. Adults over 38 with chronic knee osteoarthritis, moderate to severe pain (NRS >5), and Kellgren-Lawrence grade 2–3 disease are eligible and randomized into two arms. Outcomes focus on pain reduction and function over follow-up to see if adding dextrose provides greater and possibly longer-lasting analgesia than anesthetic alone.

Why it matters

Potential benefit: If successful, adding dextrose could provide greater and longer-lasting pain relief and improved knee function without destroying nerve tissue.

How similar studies have gone: Perineural prolotherapy is a relatively new approach with some initial positive reports suggesting benefit, but larger randomized trials are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients of both sexes
2. Age \>38 years
3. Body Mass Index (BMI) up to 42 kg/m2
4. Diagnosis of knee osteoarthritis, according to the clinical criteria of the American College of Rheumatology. Osteoarthritis if the following combinations are present:

   A, B, C, D or A, B, E or A, D, E:

   A) Knee pain most days of the previous month B) Cracking during active joint movement C) Morning stiffness lasting at least 30 minutes D) Age at least 38 years E) Bone swelling of the affected knee on physical examination
5. Chronic knee pain on the Numerical Rating Scale (NRS) \> 5 for at least 3 months prior to the study
6. Grade 2 or 3 osteoarthritis, according to the Kellgern-Lawrence classification
7. Pain, creaking, and stiffness in the knee joint that persists for at least three months prior to the study.

Exclusion Criteria:

1. Any infection of the skin of the knee joint, such as cellulitis, or periarticular or intraarticular infection during the last 3 months
2. Poorly controlled diabetes mellitus or connective tissue disease affecting the knee joint
3. History of previous total knee arthroplasty or other knee surgery.
4. History of periarticular or intraarticular injection of corticosteroids, local anesthetic, hyaluronic acid, platelet-rich plasma, radiofrequency, prolotherapy within the last trimester
5. History of knee injury or fracture within the last 3 months
6. History of acute lumbosacral radiculopathy or peripheral neuropathy, neurological, psychiatric disease
7. Pain limited in the posterior aspect of the knee
8. History of limb malignancy
9. History of bleeding disorder
10. Pregnancy
11. Allergy to local anesthetics, needle phobia
12. Difficulty communicating (severe hearing loss, dementia, language problems)
13. Non-guaranteed transportation to hospital for treatments and re-evaluations

Where it's running

  • University General Hospital of Athens "Attikon" - National and Kapodistrian University of Athens Medical School
    Athens, Attica, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.